Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hultman

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Toxicology|January 25, 2005
The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible miceBo Häggqvist, Said Havarinasab, Erik Björn, et al.
Chemical Research in Toxicology|January 19, 2010
Toxicology of autoimmune diseasesK Michael Pollard, Per Hultman, Dwight H Kono
Toxicology and Applied Pharmacology|April 3, 2007
Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible miceSaid Havarinasab, Erik Björn, Jesper B Nielsen, et al.
Scandinavian Journal of Urology and Nephrology|December 14, 2011
HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladderHans Olsson, Ing-Marie Fyhr, Per Hultman, et al.
Analytical Chemistry|November 25, 2003
Determination of methylmercury, ethylmercury, and inorganic mercury in mouse tissues, following administration of thimerosal, by species-specific isotope dilution GC-inductively coupled plasma-MSJohanna Qvarnström, Lars Lambertsson, Said Havarinasab, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Costimulation requirements of induced murine systemic autoimmune diseaseK Michael Pollard, Marc Arnush, Per Hultman, et al.
BMC Urology|January 30, 2013
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1Hans Olsson, Per Hultman, Johan Rosell, et al.
ISRN Urology|January 11, 2013
Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancerHans Olsson, Per Hultman, Nastaran Monsef, et al.
Lakartidningen|October 21, 2005
[Renewed medical education in Linkoping. Problem-based learning, basic science and public health intensified]Björn Bergdahl, Christina Eintrei, Anna Fyrenius, et al.
Plos One|July 18, 2018
Bank1 and NF-kappaB as key regulators in anti-nucleolar antibody developmentHammoudi Alkaissi, Said Havarinasab, Jesper Bo Nielsen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Toxicology|January 25, 2005
The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible miceBo Häggqvist, Said Havarinasab, Erik Björn, et al.
Chemical Research in Toxicology|January 19, 2010
Toxicology of autoimmune diseasesK Michael Pollard, Per Hultman, Dwight H Kono
Toxicology and Applied Pharmacology|April 3, 2007
Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible miceSaid Havarinasab, Erik Björn, Jesper B Nielsen, et al.
Scandinavian Journal of Urology and Nephrology|December 14, 2011
HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladderHans Olsson, Ing-Marie Fyhr, Per Hultman, et al.
Analytical Chemistry|November 25, 2003
Determination of methylmercury, ethylmercury, and inorganic mercury in mouse tissues, following administration of thimerosal, by species-specific isotope dilution GC-inductively coupled plasma-MSJohanna Qvarnström, Lars Lambertsson, Said Havarinasab, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Costimulation requirements of induced murine systemic autoimmune diseaseK Michael Pollard, Marc Arnush, Per Hultman, et al.
BMC Urology|January 30, 2013
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1Hans Olsson, Per Hultman, Johan Rosell, et al.
ISRN Urology|January 11, 2013
Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancerHans Olsson, Per Hultman, Nastaran Monsef, et al.
Lakartidningen|October 21, 2005
[Renewed medical education in Linkoping. Problem-based learning, basic science and public health intensified]Björn Bergdahl, Christina Eintrei, Anna Fyrenius, et al.
Plos One|July 18, 2018
Bank1 and NF-kappaB as key regulators in anti-nucleolar antibody developmentHammoudi Alkaissi, Said Havarinasab, Jesper Bo Nielsen, et al.
Pageof 4